{
  "meta": {
    "title": "Colours_In_Medicine_Mini_Test_-_Tmt",
    "url": "https://brainandscalpel.vercel.app/colours-in-medicine-mini-test-tmt-d242ed33.html",
    "scrapedAt": "2025-11-30T12:46:16.219Z"
  },
  "questions": [
    {
      "text": "A child is brought to the OPD because of repeated attacks of dermatitis. On examination, ulceration and scarring can be seen on the sun-exposed areas like his face and limbs. He also has reddish-brown discolouration of teeth. On investigation, urine discoloration is observed as shown in the image below. What is the likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Polycystic kidney disease"
        },
        {
          "id": 2,
          "text": "Congenital erythropoietic porphyria"
        },
        {
          "id": 3,
          "text": "Paroxysmal nocturnal hematuria"
        },
        {
          "id": 4,
          "text": "Myoglobinuria"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The image shows reddish discoloration of urine known as a <strong>port-wine appearance</strong>. The clinical scenario describes <strong>photosensitivity</strong> and <strong>erythrodontia </strong>(<span><span>reddish-brown </span></span>discoloration of teeth). All these features are suggestive of <strong>congenital erythropoietic porphyria</strong>.</p>\n<p>Congenital erythropoietic porphyria also known as <strong>Gunther's disease</strong> is <strong>autosomal recessive</strong> porphyria due to the <strong>uroporphyrinogen III synthase</strong> defect. It presents with <strong>non-immune hydrops</strong> in utero or shortly after birth. <strong>Severe cutaneous photosensitivity</strong> is present. <strong>Uroporphyrin I and coproporphyrin I</strong> accumulate in teeth, bone marrow, erythrocytes, plasma urine, and feces.</p>\n<p>The most characteristic presentation is <strong>port-wine urine</strong> or <strong>pink staining </strong>of diapers by urine. <strong>Reddish-brown teeth</strong> are seen under normal light and when illuminated with UV light, the teeth show a <strong>reddish fluorescence</strong> phenomenon known as erythrodontia (as shown in the image below).</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/7bb06248d2c74a1996bb3ae8d66d684cx422x713.PNG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Types of porphyria</h3><p>Clinically porphyrias can be classified into:</p>\n<ul>\n<li>Hepatic porphyria: The overproduction of heme pathway intermediates occurs primarily in the liver.</li>\n<li>Erythropoietic porphyria: The overproduction of heme pathway intermediates occurs primarily in bone marrow erythroid cells.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2370f6a3e9e64db5b0d342d7fc4a410fx1280x1964.JPEG\" alt=\"Pearl Image\"><table>\n<tbody>\n<tr>\n<td>\n<div><span><strong>Porphyria type</strong></span></div>\n</td>\n<td>\n<div><span><strong>Deficient </strong> <strong>enzyme</strong></span></div>\n</td>\n<td>\n<div><span><strong>Lab findings</strong></span></div>\n</td>\n<td> </td>\n<td>\n<div><span><strong>Symptoms</strong></span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>X-linked dominant protoporphyria</span></div>\n<div><span>(XLDPP)</span></div>\n</td>\n<td>\n<div><span>δ-aminolevulinate synthase 2</span></div>\n<div><span>(ALAS - 2)</span></div>\n</td>\n<td><span>Decreased RBC count and hemoglobin</span></td>\n<td>\n<div><span>Cutaneous photosensitivity</span></div>\n</td>\n<td>\n<div><span>Photosensitivity</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Aminolevulinate dehydratase deficiency porphyria</span></div>\n<div><span>(ALADP)</span></div>\n</td>\n<td>\n<div><span>δ-aminolevulinate dehydratase</span></div>\n<div><span>(ALAD)</span></div>\n</td>\n<td><span>Increased urinary ALA and coproporphyrin III </span></td>\n<td><span>Neurovisceral symptoms</span></td>\n<td>\n<div><span>Abdominal pain, neuropathy</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Acute intermittent porphyria</span></div>\n<div><span>(AIP)</span></div>\n</td>\n<td>\n<div><span>Hydroxymethylbilane synthase</span></div>\n<div><span>(Uroporphyrin I synthase)</span></div>\n</td>\n<td><span>Increased urinary ALA and PBG </span></td>\n<td><span>Neurovisceral symptoms </span></td>\n<td>\n<div><span>Periodic abdominal pain, peripheral neuropathy, psychiatric symptoms, tachycardia</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Congenital Erythropoietic porphyria</span></div>\n<div><span>(CEP)</span></div>\n</td>\n<td>\n<div><span>Uroporphyrinogen III synthase</span></div>\n<div><span>(UROS)</span></div>\n</td>\n<td><span>Increased urinary, fecal and red cell uroporphyrin I</span></td>\n<td><span>Cutaneous photosensitivity</span></td>\n<td>\n<div><span>Severe photosensitivity with erythema, swelling and blistering, hemolytic anemia, splenomegaly</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Porphyria cutanea tarda (PCT)</span></div>\n</td>\n<td>\n<div><span>Uroporphyrinogen decarboxylase</span></div>\n<div><span>(UROD)</span></div>\n</td>\n<td><span>Increased uroporphyrin I</span></td>\n<td><span> </span>\n<div><span>Cutaneous photosensitivity</span></div>\n</td>\n<td>\n<div><span>Photosensitivity with vesicles and bullae</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Hereditary coproporphyria</span></div>\n<div><span>(HCP)</span></div>\n</td>\n<td>\n<div><span>Coproporphyrinogen oxidase</span></div>\n<div><span>(CPOX)</span></div>\n</td>\n<td><span>Increased urinary ALA, PBG, and coproporphyrin III and fecal coproporphyrin III</span></td>\n<td><span>Both</span></td>\n<td>\n<div><span>Photosensitivity, neurologic symptoms, abdominal colic</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Variegate porphyria</span></div>\n<div><span>(VP)</span></div>\n</td>\n<td>\n<div><span>Protoporphyrinogen oxidase</span></div>\n<div><span>(PPOX)</span></div>\n</td>\n<td><span>Increased urinary ALA, PBG, and coproporphyrin III and fecal protoporphyrin IX</span></td>\n<td><span>Both</span></td>\n<td>\n<div><span>Photosensitivity, neurologic symptoms, developmental delay</span></div>\n</td>\n</tr>\n<tr>\n<td>\n<div><span>Erythropoietic protoporphyria</span></div>\n<div><span>(EPP)</span></div>\n</td>\n<td>\n<div><span>Ferrochelatase</span></div>\n<div><span>(FECH)</span></div>\n</td>\n<td><span>Increased fecal and red cell protoporphyrin IX </span></td>\n<td><span>Cutaneous photosensitivity</span></td>\n<td>\n<div><span>Non-blistering Photosensitivity with skin lesions</span></div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<div><span> </span></div>\n<div><span>Most porphyrias are <strong>autosomal dominant</strong> <strong>except:</strong></span></div>\n<div>\n<ul>\n<li><span>ALAD enzyme deficiency porphyria</span></li>\n<li><span>Congenital erythropoietic porphyria</span></li>\n<li><span>Erythropoietic protoporphyria</span></li>\n<li><span>X-linked protoporphyria</span></li>\n</ul>\n</div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/c14875d1d84e4c5a884cceb038c04773.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6308",
      "difficulty": "easy"
    },
    {
      "text": "According to the Anemia Mukt Bharat Scheme, which of the following IFA (Iron Folic acid) tablets is to be given to a lactating mother of a 3-month-old infant?",
      "choices": [
        {
          "id": 1,
          "text": "1 red color IFA tablet weekly"
        },
        {
          "id": 2,
          "text": "1 red color IFA tablet daily"
        },
        {
          "id": 3,
          "text": "1 pink color IFA tablet weekly"
        },
        {
          "id": 4,
          "text": "1 blue color IFA tablet weekly"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>According to the Anemia Mukt Bharat Scheme,&nbsp;<strong>lactating mothers</strong> of 0 to 6-month-old children are given a&nbsp;<strong>daily </strong>dose&nbsp;of&nbsp;<strong><span>red</span> color </strong>IFA tablet containing&nbsp;<strong>60 mg</strong> of elemental <strong>iron</strong> and <strong>500</strong>&nbsp;<strong>mcg</strong> of folic acid.</p>\n<p><strong>Weekly </strong>doses of<strong> red color </strong>IFA tablets (Option A) containing&nbsp;<strong>60 mg</strong> of elemental <strong>iron</strong> and <strong>500 mcg</strong> of <strong>folic acid</strong> are given to<strong> women of&nbsp;reproductive&nbsp;age&nbsp;</strong>(non-pregnant, non-lactating), between&nbsp;<strong>20-49 years</strong> of age.</p>\n<p><strong>Children&nbsp;</strong>between<strong>&nbsp;5-9 years of age</strong>&nbsp;are given <strong><span>pink</span> color</strong> (Option C) sugar-coated tablets containing&nbsp;<strong>45 mg </strong>of elemental <strong>iron </strong>and<strong> 400 mcg </strong>of<strong> folic acid</strong>&nbsp;tablets&nbsp;<strong>once a&nbsp;week</strong>.</p>\n<p><strong><span>Blue</span>&nbsp;color</strong> (Option D) tablets containing&nbsp;<strong>60 mg</strong> of elemental <strong>iron</strong> and <strong>500 mcg</strong> of <strong>folic acid</strong> can be given to <strong>school-going</strong> adolescent <strong>girls</strong> and <strong>boys</strong> of 10-19 years and <strong>out-of-school adolescent girls</strong> of age 10-19 years.</p>\n<p>The <strong>Anemia Mukt Bharat scheme</strong>&nbsp;is an initiative that aims to <strong>strengthen</strong> the existing mechanisms and foster newer strategies for <strong>tackling anemia</strong>. It focuses on <strong>six</strong> <strong>target</strong> <strong>beneficiary</strong> <strong>groups</strong>, through <strong>six interventions</strong> and <strong>six institutional</strong> mechanisms to achieve their target by 2022.</p>\n<p>Interventions include:</p>\n<ul>\n<li>Prophylactic <strong>iron </strong>and<strong> folic acid</strong> supplementation.</li>\n<li><strong>Deworming.</strong></li>\n<li>Intensified year-round Behaviour Change Communication Campaign (Solid Body, Smart Mind) including ensuring<strong> delayed cord clamping</strong> in newborns.</li>\n<li><strong>Testing</strong> of <strong>anemia</strong> using digital methods and point-of-care treatment.</li>\n<li>Mandatory provision of Iron and Folic Acid <strong>fortified foods</strong> in government-funded health programs.</li>\n<li>Addressing <strong>non-nutritional</strong> <strong>causes</strong> of anemia in endemic pockets, with a special focus on malaria, hemoglobinopathies, and fluorosis.</li>\n</ul><hr><h3>Related Pearl: Prophylactic Iron and Folic Acid (IFA) Supplementation</h3><p>According to the&nbsp;<strong>Anemia Mukt Bharat 2018 scheme,</strong>&nbsp;giving<strong> IFA</strong> to children, adolescents, women of reproductive age, and pregnant women,&nbsp;irrespective of their anemia status, is a key intervention.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Age group</strong></td>\n<td><strong>Dose</strong></td>\n<td><strong>Frequency</strong></td>\n<td><strong>Tablet Color</strong></td>\n</tr>\n<tr>\n<td><span>Children</span><br /><span>6-59 months of age</span></td>\n<td>\n<p>&nbsp;</p>\n<p>1 mL iron and folic acid syrup</p>\n<p>Each mL contains&nbsp;<strong>20 mg</strong> elemental<strong> iron </strong>+<strong> 100 mcg</strong> of<strong> folic&nbsp;acid</strong></p>\n</td>\n<td>\n<p>Bi-weekly</p>\n</td>\n<td>&nbsp;Syrup</td>\n</tr>\n<tr>\n<td><span>Children </span><br /><span>5-9 years of age</span></td>\n<td>\n<p>&nbsp;</p>\n<p>1 Iron and folic&nbsp;acid tablet</p>\n<p><strong>45 mg</strong> elemental iron +<strong> 400 mcg</strong> folic acid,</p>\n<p>Sugar-coated</p>\n</td>\n<td>Weekly&nbsp;</td>\n<td>&nbsp;Pink</td>\n</tr>\n<tr>\n<td>\n<p><span>School-going adolescent girls and Boys</span><br /><span>10-19 years of age</span></p>\n<p><span>Out-of-school adolescent girls</span><br /><span>10-19 years of age</span></p>\n</td>\n<td>\n<p>&nbsp;</p>\n<p>1 iron and folic acid tablet</p>\n<p><strong>60&nbsp;mg&nbsp;</strong>elemental iron +<strong> 500 mcg </strong>folic acid,&nbsp;</p>\n<p>Sugar-coated</p>\n</td>\n<td>Weekly&nbsp;</td>\n<td>&nbsp;Blue</td>\n</tr>\n<tr>\n<td>\n<p><span>Women of reproductive age (non-pregnant, non-lactating) </span><br /><span>20-49 years</span></p>\n<p><span>(Under Mission Parivar Vikas)</span></p>\n</td>\n<td>\n<p>&nbsp;</p>\n<p>1 iron and folic acid tablet</p>\n<p><strong>60</strong>&nbsp;<strong>mg</strong> elemental iron +<strong> 500 mcg </strong>folic acid,&nbsp;</p>\n<p>Sugar-coated&nbsp;</p>\n</td>\n<td>Weekly&nbsp;</td>\n<td>&nbsp;Red</td>\n</tr>\n<tr>\n<td><span>Pregnant Women and Lactating Mothers </span><br /><span>of 0-6 months child</span></td>\n<td>\n<p>&nbsp;</p>\n<p>1 iron and folic acid tablet starting from the <strong>fourth month</strong> of pregnancy is continued throughout pregnancy (minimum 180 days). It should also be continued for 180 days post-partum.</p>\n<p><strong>60</strong>&nbsp;<strong>mg </strong>elemental iron +<strong> 500 mcg </strong>folic acid,</p>\n<p>Sugar-coated and red color</p>\n</td>\n<td>Daily&nbsp;</td>\n<td>Red&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Note 1:<strong> Prophylaxis with iron</strong> should be <strong>withheld</strong> in case of <strong>acute illness</strong> (fever, diarrhea, pneumonia, etc.) and in a known case of <strong>thalassemia major</strong>/ history of <strong>repeated blood transfusion</strong>. In cases of children with severe acute malnutrition (SAM), IFA supplementation should be continued as per the SAM management protocol.</p>\n<p>Note 2: All women in the reproductive age group in the pre-conception period and up to the first trimester of the pregnancy are advised to have 400 mcg of folic acid tablets, daily, to reduce the incidence of neural tube defects in the fetus.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF8691",
      "difficulty": "easy"
    },
    {
      "text": "Arrange the following colour codes used in triage in the increasing order of priority starting with the least priority.<div class='question-desc-html'><ol>\n<li>Red</li>\n<li>Black&nbsp;</li>\n<li>Yellow</li>\n<li>Green</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "2 ->1 -> 4 ->3"
        },
        {
          "id": 2,
          "text": "4 ->3 ->1 ->2"
        },
        {
          "id": 3,
          "text": "2 ->4 ->3 ->1"
        },
        {
          "id": 4,
          "text": "2 ->1 ->3 ->4"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The correct sequence of triage color coding priority is <span><strong>black</strong></span> (least priority) -&gt; <span><strong>Green</strong></span> -&gt; <span><strong>Yellow</strong></span> -&gt; <span><strong>Red</strong></span>(Highest Priority)</p>\n<p>Triage means &lsquo;to sort&rsquo; and is essential in the management of <strong>mass casualties</strong>. It aims to identify the patients in whom <strong>treatment at the earliest</strong> produces the <strong>maximum benefit</strong>. It is carried out at the site of the disaster to determine the <strong>priority</strong> for<strong> immediate medical attention</strong>, <strong>transportation</strong>, and <strong>admission</strong> to the hospital.</p>\n<p>Triage includes <strong>rapid classification</strong> of the injured based on their <strong>injuries</strong> and the <strong>chances of survival</strong> with prompt medical intervention.&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Priority</strong></td>\n<td><strong>Colour</strong></td>\n<td><strong>Medical need</strong></td>\n<td><strong>Clinical status</strong></td>\n</tr>\n<tr>\n<td>First (I)</td>\n<td><span>Red</span></td>\n<td>Immediate</td>\n<td>Critical, but likely to survive if the treatment given early</td>\n</tr>\n<tr>\n<td>Second (II)</td>\n<td><span>Yellow</span></td>\n<td>Urgent</td>\n<td>Critical, likely to survive if the treatment given within hours</td>\n</tr>\n<tr>\n<td>Third (III)</td>\n<td><span>Green</span></td>\n<td>Non-urgent</td>\n<td>Stable, likely to survive even if treatment is delayed for hours to days</td>\n</tr>\n<tr>\n<td>Last (0)</td>\n<td><span>Black</span></td>\n<td>Unsalvageable</td>\n<td>Not breathing, pulseless, so severely injured that no medical care is likely to help</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><p>Note:&nbsp;<strong><span data-preserver-spaces=\"true\">Reverse triage&nbsp;</span></strong><span data-preserver-spaces=\"true\">is used&nbsp;</span><span data-preserver-spaces=\"true\">in a situation where the&nbsp;</span><strong><span data-preserver-spaces=\"true\">less injured</span></strong><span data-preserver-spaces=\"true\">&nbsp;are treated&nbsp;</span><strong><span data-preserver-spaces=\"true\">earlier</span></strong><span data-preserver-spaces=\"true\">&nbsp;than the ones that are injured more, allowing for&nbsp;<strong>faster turnover</strong>. It is followed in this situation to&nbsp;<strong>discharge</strong>&nbsp;<strong>existing patients</strong>&nbsp;and to&nbsp;<strong>increase</strong>&nbsp;the&nbsp;<strong>surge capacity</strong>&nbsp;of the hospital to&nbsp;<strong>accommodate</strong>&nbsp;for the&nbsp;<strong>natural disaster.</strong>&nbsp;Here,&nbsp;<strong>non-emergent</strong>&nbsp;patients currently admitted to the hospital are&nbsp;<strong>discharged</strong>&nbsp;to allow for the acute increase in incoming patients.</span></p><hr><h3>Related Pearl: Triage Colour Coding</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/515d17fd0b684f8b9cd1fd57ef97b7e6x454x304.PNG\" alt=\"Pearl Image\"><p>&nbsp;<strong>Triage system </strong>consists of <strong>four colour codes:</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Color code</strong></td>\n<td><strong>Type of patients</strong></td>\n<td><strong>Examples</strong></td>\n</tr>\n<tr>\n<td><span>Red (High priority)<br /></span></td>\n<td>\n<p>Need for<strong> immediate resuscitation or surgery</strong> in the next<strong> 6 hours</strong> or transfer.</p>\n<p>May survive if timely medical intervention can be given</p>\n</td>\n<td>\n<ul>\n<li>Tension pneumothorax</li>\n<li>Airway obstruction</li>\n<li>Hemothorax</li>\n<li>Cardiac tamponade</li>\n<li>Acute circulatory arrest</li>\n<li>Major intra-abdominal bleed etc.</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><span>Yellow (Medium priority)<br /></span></td>\n<td>\n<p>Possible <strong>resuscitation or surgery</strong> in the <strong>next 24 hours</strong>.</p>\n<p>Likely to survive if prompt treatment is given.</p>\n</td>\n<td>\n<ul>\n<li>Compound fractures</li>\n<li>Degloving injuries</li>\n<li>Pelvic fracture</li>\n<li>Spinal injuries</li>\n<li>Moderate head injury</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><span>Green (Low priority)<br /></span></td>\n<td>\n<p><strong>Ambulatory patients</strong> or minor illnesses.</p>\n<p>Likely to survive if treatment is slightly delayed.</p>\n</td>\n<td>\n<ul>\n<li>Simple fractures</li>\n<li>Minor lacerations etc.</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Black (Least priority)</td>\n<td>\n<p><strong>Dead or moribund</strong> patients.</p>\n</td>\n<td>\n<ul>\n<li>Severe brain injury</li>\n<li>Major damage / disruption to chest wall and abdominal structures</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1219",
      "difficulty": "easy"
    },
    {
      "text": "A senior resident during his ward rounds advises the nurse to insert an 18 gauge IV cannula for a patient and start fluids. Which of the following cannulas will she use?",
      "choices": [
        {
          "id": 1,
          "text": "1"
        },
        {
          "id": 2,
          "text": "2"
        },
        {
          "id": 3,
          "text": "3"
        },
        {
          "id": 4,
          "text": "4"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>An <strong>18 gauge</strong> IV cannula is <span><strong>green</strong></span> in color as shown in image 1. </p>\n<p>In the above image, the cannulae numbered 1 to 4 are respectively:</p>\n<ol>\n<li><strong>18G</strong> - <span>green</span></li>\n<li><strong>20G</strong> - <span>pink</span></li>\n<li><strong>22G</strong> - <span>blue</span></li>\n<li><strong>24G</strong> - <span>yellow</span></li>\n</ol>\n<p>A<strong> standard wire gauge</strong> (SWG) is used to size cannulas. It is a measure of the cross-sectional area. It refers to the number of wires of the same size as the cannula that could pass through a hole of a standard size in parallel. Therefore <strong>larger cannulae </strong>have a<strong> smaller gauge number</strong>.</p><hr><h3>Related Pearl: Color Coding of Intravenous Cannulae</h3><table>\n<tbody>\n<tr>\n<td><strong>Size</strong></td>\n<td><strong>Color Coding</strong></td>\n<td><strong>Flow Rate</strong></td>\n<td><strong>Uses</strong></td>\n</tr>\n<tr>\n<td><span>14G</span></td>\n<td><strong><span>Orange</span></strong></td>\n<td>270ml/min</td>\n<td>Trauma Patients, Rapid, Large Volume replacement</td>\n</tr>\n<tr>\n<td>16G</td>\n<td><strong><span>Grey</span></strong></td>\n<td>236ml/min</td>\n<td>Trauma Patients, Major Surgery, Intra Partum/Post Partum, GI bleeds, Multiple blood transfers, High volume of Fluids</td>\n</tr>\n<tr>\n<td>17G</td>\n<td><strong>White</strong></td>\n<td>125ml/min</td>\n<td>Newly added</td>\n</tr>\n<tr>\n<td>18G</td>\n<td><span><strong><span>Green</span></strong></span></td>\n<td>103 ml/min</td>\n<td>Blood products, delivery of irritant medications, major surgery, contrast study</td>\n</tr>\n<tr>\n<td>20G</td>\n<td><strong><span>Pink</span></strong></td>\n<td>67ml/min</td>\n<td>General use IV maintenance, IV antibiotics, IV analgesics</td>\n</tr>\n<tr>\n<td>22G</td>\n<td><span><strong><span>Blue</span></strong></span></td>\n<td>42 ml/min</td>\n<td>Small or Fragile veins, Cytotoxic Therapy</td>\n</tr>\n<tr>\n<td>24G</td>\n<td><strong><span>Yellow</span></strong></td>\n<td>20ml/min</td>\n<td>For pediatric Usage</td>\n</tr>\n<tr>\n<td>26G</td>\n<td><span><strong><span>Violet</span></strong></span></td>\n<td>13ml/min</td>\n<td>Newly added</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/515d7b9f35424e998aea69268f7d5278.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF8708",
      "difficulty": "easy"
    },
    {
      "text": "A patient with infective endocarditis is started on an intravenous antibiotic and has developed the following reaction within a few minutes of starting it. What is the most likely antibiotic which can cause this reaction?",
      "choices": [
        {
          "id": 1,
          "text": "Daptomycin"
        },
        {
          "id": 2,
          "text": "Vancomycin"
        },
        {
          "id": 3,
          "text": "Clindamycin"
        },
        {
          "id": 4,
          "text": "Chloramphenicol"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given image shows<strong> <span>red</span> man syndrome </strong>and the drug causing it is <strong>vancomycin.</strong></p>\n<p>Red man syndrome is a common adverse effect of the <strong>rapid administration</strong> of vancomycin. The redness is due to the release of <strong>histamine</strong> in the body. This should always be anticipated while giving vancomycin infusion and can be prevented by <strong>prior administration of antihistamines</strong> and <strong>prolonging the infusion </strong>period to 1 to 2 hours.</p>\n<p>Other such syndromes associated with drugs are:</p>\n<ul>\n<li>Blue man syndrome - Amiodarone</li>\n<li>Gray baby syndrome - Chloramphenicol</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/da80a218b6c64dbab05dfa0c33bf5dd3.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD0516",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following statements is not true regarding the tape shown in the image below?",
      "choices": [
        {
          "id": 1,
          "text": "Used in children aged 6-59 months."
        },
        {
          "id": 2,
          "text": "Reading in the red zone is considered to be severe chronic malnutrition"
        },
        {
          "id": 3,
          "text": "Reading in the yellow zone is considered to be moderate acute malnutrition"
        },
        {
          "id": 4,
          "text": "Reading in the green zone is considered to be normal"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given image shows <strong>Shakir's tape</strong>. The reading in the <strong><span>red</span> zone</strong>&nbsp;is considered to be&nbsp;severe<strong> acute</strong> malnutrition (<strong>SAM</strong>).</p>\n<p><strong>Shakir's tape</strong> is used for the screening of malnourished children and for their admission into therapeutic feeding centers. It is useful mainly for <strong>frontline field workers</strong>.&nbsp;The target population is malnourished children or those at risk, aged <strong>6-59 months&nbsp;</strong>(Option A).</p>\n<p>It is used for the measurement of <strong>mid-upper arm circumference</strong>. To locate the midpoint of the left arm, the arm is flexed at the right angle, and the mid-point is marked <strong>halfway between the acromion and olecranon process</strong>. Color coding of the measurements and their significance is as follows:</p>\n<ul>\n<li aria-level=\"1\"><span><strong>Red</strong></span> is from <strong>0</strong> to <strong>11.5</strong> cm - <strong>Severe acute malnutrition</strong></li>\n<li aria-level=\"1\"><span><strong>Yellow</strong></span> is from <strong>11.5</strong> to <strong>12.5</strong> cm - <strong>Moderate acute malnutrition&nbsp;</strong>(Option C)</li>\n<li aria-level=\"1\"><span><strong>Green</strong></span> is from <strong>12.5 </strong>to<strong> 26.5</strong> cm - <strong>Normal&nbsp;</strong>(Option D)</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c1f72910281748efb49f88144b1b1571x1280x1350.JPEG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/87cde44e9fb3464e941935d49b41c438.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF8719",
      "difficulty": "medium"
    },
    {
      "text": "Gray baby syndrome is caused due to intake of which of the following drugs?",
      "choices": [
        {
          "id": 1,
          "text": "Chloramphenicol"
        },
        {
          "id": 2,
          "text": "Carbimazole"
        },
        {
          "id": 3,
          "text": "Valproate"
        },
        {
          "id": 4,
          "text": "Phenytoin"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong><span>Gray</span> baby syndrome</strong> occurs when high doses of <strong>chloramphenicol</strong> (100 mg/kg) were given prophylactically to neonates, especially premature babies.</p>\n<p>This syndrome usually begins <strong>2 to 9 days</strong> after starting the treatment. Initially in the first 24 hours, the baby develops <strong>vomiting</strong>, <strong>refusal to feed</strong>, irregular and rapid respiration, <strong>abdominal distention</strong>, periods of cyanosis, and passage of loose green stools. Over the next day, neonates turn to <strong>ashen-gray color</strong> and become <strong>hypothermic</strong> and&nbsp;<strong>flaccid</strong>.</p>\n<p>It happens due to the&nbsp;<strong>developmental deficiency</strong>&nbsp;of the enzyme<strong>&nbsp;glucoronyl transferase</strong>. This enzyme metabolizes chloramphenicol in neonates. Its deficiency leads to an&nbsp;<strong>inability</strong>&nbsp;to&nbsp;<strong>excrete unconjugated drugs</strong>&nbsp;adequately through renal excretion.</p>\n<p><strong>Death</strong> occurs in 40% of patients within 2 days of initial symptoms, but if there is a <strong>recovery</strong>, there are&nbsp;<strong>no sequelae </strong>usually.</p><hr><h3>Related Pearl: Teratogenic drugs and the birth defects</h3><table>\n<tbody>\n<tr>\n<td><strong>Drugs</strong></td>\n<td><strong>Adverse effects</strong></td>\n</tr>\n<tr>\n<td>Penicillamine</td>\n<td>Cutis laxa syndrome</td>\n</tr>\n<tr>\n<td><strong>Lithium</strong></td>\n<td><strong>Ebstein anomaly</strong></td>\n</tr>\n<tr>\n<td>Isotretinoin</td>\n<td>Facial-ear anomalies, heart disease, CNS anomalies</td>\n</tr>\n<tr>\n<td>Progesterone</td>\n<td>Masculinization of the female fetus</td>\n</tr>\n<tr>\n<td>Quinine</td>\n<td>Abortion, thrombocytopenia, deafness</td>\n</tr>\n<tr>\n<td>Topiramate</td>\n<td>Cleft lip</td>\n</tr>\n<tr>\n<td><strong>Valproate</strong></td>\n<td>Spina bifida, limb defects, <strong>autism spectrum disorder</strong>, facial and cardiac anomalies, <strong>Coarctation of the aorta</strong>, Aortic stenosis, Pulmonary atresia, Ventricular Septal Defect. </td>\n</tr>\n<tr>\n<td><strong>Vitamin D</strong></td>\n<td><strong>Supravalvular aortic stenosis</strong></td>\n</tr>\n<tr>\n<td><strong>Warfarin</strong></td>\n<td>Fetal bleeding, <strong>hypoplastic nasal structures</strong></td>\n</tr>\n<tr>\n<td><strong>Statins</strong></td>\n<td>Vertebral, anal, cardiac, tracheoesophageal fistula, renal, arterial, limb (<strong>VACTERAL</strong>) defects</td>\n</tr>\n<tr>\n<td><strong>Phenytoin</strong></td>\n<td>Ventricular septal defect, Atrial Septal Defect, Coarctation of the aorta, Patent Ductus Arteriosus</td>\n</tr>\n<tr>\n<td>ACE inhibitors and ARBs</td>\n<td>\n<p>Hypoplasia of organs, anuria, irreversible renal failure</p>\n</td>\n</tr>\n<tr>\n<td>Carbimazole and Methimazole</td>\n<td> \n<p>Choanal atresia, aplasia cutis, tracheoesophageal fistula and fetal goiter</p>\n</td>\n</tr>\n<tr>\n<td>Alcohol</td>\n<td>Atrial Septal Defect, Ventricular Septal Defect</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB8479",
      "difficulty": "easy"
    },
    {
      "text": "A 28-year-old male patient presents to the clinic with a 2-month history of hypopigmented lesions with occasional itching.  Wood's lamp examination was performed, and the finding is shown below. What is the likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Pityriasis versicolor"
        },
        {
          "id": 2,
          "text": "Vitiligo"
        },
        {
          "id": 3,
          "text": "Tinea capitis"
        },
        {
          "id": 4,
          "text": "Albinism"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given clinical scenario of <strong>hypopigmented lesions</strong> and an image showing<span><strong> ivory</strong> or </span><strong><span>milky-white</span> fluorescence</strong> on <strong>Wood's lamp</strong> examination are suggestive of <strong>vitiligo</strong>.</p>\n<p><strong>Vitiligo</strong> is a localized depigmentation that occurs due to a <strong>progressive loss in the melanocytes </strong>in the <strong>basal layer </strong>of the skin.<strong> </strong>Vitiligo shows a strong association with several <strong>autoimmune disorders</strong>, the <strong>strongest</strong> one being autoimmune <strong>thyroid</strong> <strong>disorders</strong> (hyperthyroidism and hypothyroidism).</p>\n<p>The lesions become apparent between <strong>20-30 years</strong> of age. Hypopigmented macules in vitiligo are commonly found in the <strong>hips, dorsum </strong>of the<strong> hands/fingers</strong>, <strong>feet, elbows, knees, </strong>and<strong> ankle areas.</strong> These are the areas of repeated friction. <strong>Koebner phenomenon </strong>is seen, which is the development of <strong>lesions at the site of trauma</strong> on the uninvolved skin.</p>\n<p>Under the<strong> Wood's lamp </strong>examination, the depigmented areas emit an<strong> ivory-white </strong>or<strong> milky-white fluorescence </strong>and<strong> appear sharply demarcated</strong>. Woods lamp is helpful in diagnosing vitiligo, especially in fair-skinned people whose lesions may not be evident to the naked eye.</p>\n<p>The topical application of <strong>corticosteroids</strong> is the <strong>first line of treatment</strong>. Topical calcineurin inhibitors like pimecrolimus and <strong>tacrolimus</strong> have also been successful. <strong>Psoralen photochemotherapy,</strong> khellin, and selective <strong>ultraviolet B therapy</strong> are used as <strong>second-line treatments</strong>. In patients who do not respond to this treatment, surgical grafting techniques can be used, where the melanocytes from a normal pigmented area are transferred to a non-pigmented area. In patients with extensive vitiligo, where only a few pigmented areas are left, depigmentation can be done.</p><hr><h3>Related Pearl: Wood's lamp examination</h3><p><strong>Wood's lamp examination</strong> is a <strong>diagnostic</strong> test wherein the <strong>skin</strong> or <strong>hair</strong> is examined under exposure to the <strong>black</strong> <strong>light</strong> emitted by the <strong>Wood</strong> <strong>lamp</strong>.</p>\n<p>Blacklight is invisible to the naked eye because it is in the ultraviolet spectrum, with a wavelength just shorter than the color violet. The lamp glows violet in a dark environment because it also emits some light in the violet part of the electromagnetic spectrum.</p>\n<p>A traditional Wood lamp is a low-output mercury arc covered by a <strong>Wood</strong> <strong>filter</strong> (<strong>barium</strong> <strong>silicate</strong> and <strong>9% nickel oxide</strong>) and emits light at <strong>wavelength</strong> <strong>320</strong>–<strong>450</strong> <strong>nm</strong> (<strong>peak</strong> <strong>365</strong> <strong>nm</strong>).</p>\n<p><strong>Table</strong>: Various diseases and their color on Wood’s lamp examination</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disease</strong></p>\n</td>\n<td>\n<p><strong>Colour on Wood’s Light</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Tinea capitis</p>\n<p> </p>\n</td>\n<td>\n<p><strong>Microsporum species</strong>: brilliant green (M. canis, M. audouinii, M. ferrugineum, M. distortum)</p>\n<p><strong>Trichophyton schoenleinii</strong>: dull blue</p>\n<p>Most <strong>Trichophyton </strong>species, with the exception of T. schoenleini<em>i</em>, are non-fluorescent</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Erythrasma</p>\n</td>\n<td>\n<p>Coral pink</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pityriasis versicolor</p>\n</td>\n<td>\n<p>Faint yellow</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Pseudomonas</p>\n</td>\n<td>\n<p>Green</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Scabies</p>\n</td>\n<td>\n<p>Fluorescein solution fills the burrows and fluoresces on Wood’s light.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Porphyria</p>\n</td>\n<td>\n<p>Urine, feces, blister fluid fluoresce red or pink</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Vitiligo</p>\n</td>\n<td>\n<p>Ivory or milky white</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2242a0f1720540909975b6853638f735x800x531.JPEG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/95373cdf5568475f989b7429ca4e2b79.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF8716",
      "difficulty": "medium"
    },
    {
      "text": "During your internship, you notice the following cylinder attached to an anesthetic machine present in the operation theater.  In which of the following scenario the inhalational agent from this can be used?",
      "choices": [
        {
          "id": 1,
          "text": "Tympanic membrane grafting"
        },
        {
          "id": 2,
          "text": "Sedation in dental procedure"
        },
        {
          "id": 3,
          "text": "Intestinal obstruction"
        },
        {
          "id": 4,
          "text": "Pulmonary air cyst"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given image shows a <strong><span>blue</span> color cylinder</strong> that is used to store <strong>n</strong><strong>itrous</strong> <strong>oxide</strong> (N<sub>2</sub>O).<strong> </strong>It is commonly used for analgesia and <strong>sedation in dental procedures</strong>.</p>\n<p>Nitrous oxide is <strong>35 times more soluble</strong> than nitrogen in the blood. It tends to <strong>diffuse into air-containing cavities</strong> more rapidly than nitrogen is absorbed by the bloodstream. Due to this reason nitrous oxide is <strong>contraindicated </strong>in:</p>\n<ul>\n<li>Venous or arterial air embolism</li>\n<li>Pneumothorax</li>\n<li><strong>Acute intestinal obstruction</strong> with bowel distention</li>\n<li>Intracranial air (pneumocephalus following dural closure or pneumoencephalography)</li>\n<li><strong>Pulmonary air cysts</strong></li>\n<li>Intraocular air bubbles</li>\n<li><strong>Tympanic membrane grafting</strong></li>\n</ul>\n<p><strong>Side effects </strong>of nitrous oxide are:</p>\n<ul>\n<li><strong>Megaloblastic anemia</strong></li>\n<li>Bone marrow depression</li>\n<li>Teratogenicity</li>\n<li><strong>Peripheral neuropathy</strong></li>\n</ul><hr><h3>Related Pearl: Unique features of Nitrous oxide</h3><p><strong>Concentration-effect</strong></p>\n<ul>\n<li>The blood gas partition coefficient of N<sub>2</sub>O is 35 times higher&nbsp;than O<sub>2</sub> and N<sub>2,</sub>&nbsp;hence its rapid uptake diminishes its volume and&nbsp;concentrates&nbsp;the remaining anesthetics in the alveolus.</li>\n</ul>\n<p><strong>Second-gas effect</strong></p>\n<ul>\n<li>Concentration-effect of one gas over another is known as the second gas effect</li>\n<li>Increase in the partial pressure of the <strong>2nd gas</strong> (Oxygen and volatile agents) due to the <strong>rapid uptake</strong> of N<sub>2</sub>O during <strong>induction.</strong></li>\n</ul>\n<p><strong>Diffusion hypoxia (Finks effect)</strong></p>\n<ul>\n<li><strong>Rapid elimination </strong>of N<sub>2</sub>O during recovery causes a reduction in the partial pressure of oxygen leading to<strong> hypoxia</strong></li>\n<li>Avoided by using 100% oxygen for 10 minutes during recovery from anesthesia.</li>\n</ul>\n<p><strong>Nitrous oxide in gas-filled spaces</strong></p>\n<div class=\"page\" title=\"Page 181\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li>It diffuses into air-containing cavities more rapidly than air (principally nitrogen) can be absorbed by the bloodstream</li>\n<li>If the walls surrounding the cavity are rigid, pressure rises instead of volume.</li>\n</ul>\n<p>Hence N<sub>2</sub>O is <strong>contraindicated</strong> in:</p>\n<ul>\n<li>Venous or arterial air embolism</li>\n<li>Acute intestinal obstruction</li>\n<li>Pneumocephalus, pneumothorax</li>\n<li>Pulmonary air cysts</li>\n<li>Intraocular air bubbles</li>\n<li>Tympanic membrane grafting.</li>\n</ul>\n</div>\n</div>\n</div><hr><h3>Related Pearl: Coding of gas cylinders</h3><table>\n<tbody>\n<tr>\n<td><strong>GAS</strong></td>\n<td><strong>SHOULDER COLOUR</strong></td>\n<td><strong>BODY COLOUR</strong></td>\n</tr>\n<tr>\n<td>Oxygen</td>\n<td>White</td>\n<td>Black</td>\n</tr>\n<tr>\n<td>Air</td>\n<td>White</td>\n<td>Grey</td>\n</tr>\n<tr>\n<td>Carbon dioxide</td>\n<td colspan=\"2\">Grey</td>\n</tr>\n<tr>\n<td>Nitrous oxide</td>\n<td colspan=\"2\">Blue</td>\n</tr>\n<tr>\n<td>Helium</td>\n<td colspan=\"2\">Brown</td>\n</tr>\n<tr>\n<td>Nitrogen</td>\n<td colspan=\"2\">Black</td>\n</tr>\n<tr>\n<td>Ethylene</td>\n<td colspan=\"2\">Purple</td>\n</tr>\n<tr>\n<td>Cyclopropane</td>\n<td colspan=\"2\">Orange</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Inhalational anaesthetic agents</h3><p>Inhalational agent of choice: </p>\n<table>\n<tbody>\n<tr>\n<td><strong>Indication</strong></td>\n<td><strong>Anesthetic gas</strong></td>\n</tr>\n<tr>\n<td>1. Induction </td>\n<td>Sevoflurane</td>\n</tr>\n<tr>\n<td>2. Daycare surgery</td>\n<td>Sevflurane&gt;Desflurane</td>\n</tr>\n<tr>\n<td>3. Elderly </td>\n<td>Desflurane</td>\n</tr>\n<tr>\n<td>4. Cardiac surgery</td>\n<td>Isoflurane</td>\n</tr>\n<tr>\n<td>5. Renal disease</td>\n<td>Desflurane</td>\n</tr>\n<tr>\n<td>6. Liver disease </td>\n<td>Sevoflurane &gt; Desflurane </td>\n</tr>\n<tr>\n<td>7. Neurosurgery   </td>\n<td>Sevoflurane&gt;Isoflurane</td>\n</tr>\n<tr>\n<td>8. Asthmatics</td>\n<td>Sevoflurane</td>\n</tr>\n<tr>\n<td>9. Obese patients</td>\n<td>Desflurane</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>\n<table>\n<tbody>\n<tr>\n<td><strong>Feature</strong></td>\n<td><strong>Drug</strong></td>\n</tr>\n<tr>\n<td>Most potent      </td>\n<td>Methoxyflurane &gt; Halothane </td>\n</tr>\n<tr>\n<td>Least potent     </td>\n<td>Nitrous oxide &gt; Desflurane </td>\n</tr>\n<tr>\n<td>Most epileptogenic  </td>\n<td>Enflurane</td>\n</tr>\n<tr>\n<td>Most nephrotoxic</td>\n<td>Methoxyflurane </td>\n</tr>\n<tr>\n<td>Most hepatotoxic</td>\n<td>Halothane </td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/68b269ef55234d2c8fd25edd20257dea.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF2658",
      "difficulty": "medium"
    },
    {
      "text": "Match the given amniotic fluid findings with their respective causative condition.<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td>Color of amniotic fluid</td>\n<td>Conditions</td>\n</tr>\n<tr>\n<td>1. Dark maroon</td>\n<td>a. Rh-incompatibility</td>\n</tr>\n<tr>\n<td>2. Green</td>\n<td>\n<p>b. Fetal distress</p>\n</td>\n</tr>\n<tr>\n<td>3. Golden-yellow</td>\n<td>c. Post-maturity</td>\n</tr>\n<tr>\n<td>4. Saffron</td>\n<td>d. Abruptio placenta</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>e. Intrauterine fetal demise</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "1-d, 2-b, 3-a, 4-c"
        },
        {
          "id": 2,
          "text": "1-e, 2-b, 3-a, 4-c"
        },
        {
          "id": 3,
          "text": "1- e, 2-a, 3-c, 4-b"
        },
        {
          "id": 4,
          "text": "1-a, 2-b, 3-c, 4-d"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Abnormal color of the Amniotic fluid and their causes are as follows</p>\n<table>\n<tbody>\n<tr>\n<td>Color of amniotic fluid</td>\n<td>Conditions</td>\n</tr>\n<tr>\n<td>1. <span>Dark</span> <span>maroon</span></td>\n<td>d. Abruptio placenta</td>\n</tr>\n<tr>\n<td>2. <span>Green</span></td>\n<td>\n<p>b. Fetal distress</p>\n</td>\n</tr>\n<tr>\n<td>3. <span>Golden-yellow</span></td>\n<td>a. Rh-incompatibility&nbsp;</td>\n</tr>\n<tr>\n<td>4. <span>Saffron</span></td>\n<td>c. Post-maturity&nbsp;</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Amniotic fluid in <strong>early pregnancy</strong> is <strong>colorless</strong>, but <strong>near term</strong> it becomes <strong>pale straw-colored</strong> due to the presence of exfoliated lanugo and epidermal cells from the fetal skin.&nbsp;<strong>Golden-colored&nbsp;</strong>amniotic fluid is seen in<strong>&nbsp;Rh incompatibility.&nbsp;</strong>This appearance is due to&nbsp;<strong>excess bilirubin</strong>&nbsp;in the amniotic fluid due to the hemolysis of fetal RBCs.</p>\n<p class=\"p1\"><strong><span class=\"s1\">Meconium stained (green) amniotic fluid&nbsp;</span></strong>is suggestive of&nbsp;<strong>fetal distress</strong>.</p>\n<p>In a&nbsp;<strong>post-term (&gt; 42 weeks)</strong>&nbsp;pregnancy,&nbsp;the amniotic fluid is found to be&nbsp;<strong>Saffron</strong>&nbsp;in color.</p>\n<p>In&nbsp;<strong>intrauterine death</strong>&nbsp;( absent fetal movements and FHS absent on doppler), a<strong>&nbsp;tobacco juice-colored&nbsp;</strong>amniotic fluid is seen.&nbsp;The dark color is due to the frequent presence of&nbsp;<strong>old HbA</strong>.</p>\n<p><strong>Dark red/maroon colored</strong> amniotic fluid is seen in <strong>concealed accidental hemorrhage </strong>as in cases of <strong>abruptio placenta</strong>.</p><hr><h3>Related Pearl: Indications of Amniotic Fluid Color</h3><table>\n<tbody>\n<tr>\n<td><strong>Amniotic fluid colour </strong></td>\n<td><strong>Inference</strong></td>\n</tr>\n<tr>\n<td>Colourless</td>\n<td>Early pregnancy</td>\n</tr>\n<tr>\n<td>Straw yellow&nbsp;</td>\n<td>Term pregnancy (exfoliated lanugo, epidermal cells from fetal skin)</td>\n</tr>\n<tr>\n<td>Meconium stained (green)</td>\n<td>Fetal distress (other than breech / transverse)</td>\n</tr>\n<tr>\n<td>Golden&nbsp;</td>\n<td>Rh incompatibility (excessive hemolysis of fetal RBC, excess bilirubin)</td>\n</tr>\n<tr>\n<td>Greenish yellow (saffron)</td>\n<td>Post maturity</td>\n</tr>\n<tr>\n<td>Dark red</td>\n<td>Concealed accidental hemorrhage (contamination of blood)</td>\n</tr>\n<tr>\n<td>Dark brown (tobacco juice)</td>\n<td>Intrauterine death (presence of old HbA)</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF8583",
      "difficulty": "medium"
    },
    {
      "text": "You are an intern working in the emergency department. Your resident asks you to insert Foley's catheter in a patient. You try inserting orange coded Foleys catheter but it is not possible to insert. You ask a paramedical staff to get a smaller catheter. Which one of the following catheter would you ask for?",
      "choices": [
        {
          "id": 1,
          "text": "2"
        },
        {
          "id": 2,
          "text": "3"
        },
        {
          "id": 3,
          "text": "1"
        },
        {
          "id": 4,
          "text": "4"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The Foley's catheter coded with <strong><span>green</span> color</strong> is smaller than the <span>orange</span> colored one. Therefore, this should be used in the patient. All other colors mentioned are larger than the orange coded catheters.</p>\n<p>The size of the urine catheters are measured by <strong>French (Fr). </strong><strong>&nbsp;</strong>The French scale refers to the<strong> external diameter</strong> of the catheter, and <strong>1Fr</strong> is <strong>0.3&nbsp;mm</strong> in diameter.</p>\n<p>In a patient, if there is difficulty in catheterization, a lower Fr number should be used instead.</p><hr><h3>Related Pearl: Foley's Catheter</h3><p>A&nbsp;<strong>Foley catheter</strong>&nbsp;is a thin, sterile tube inserted into the bladder to drain urine. Because it can be left in place in the bladder for a period of time, it is also called an indwelling&nbsp;<strong>catheter</strong>.</p>\n<div class=\"page\" title=\"Page 173\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p class=\"p1\"><strong>French scale</strong> corresponds to the <strong>outer diameter</strong> in millimetres, and <strong>1Fr </strong>is <strong>0.3 mm </strong>in diameter.</p>\n<p class=\"p1\">Fr. size = 3 x d, where d is the outer diameter in mm.&nbsp;</p>\n<p class=\"p1\">A 18 Fr. catheter will have a circumference of approximately 18 mm and a diameter of 6 mm.&nbsp;</p>\n<p>Note:</p>\n<p>Colour of the foleys is the colour at the baloon port as shown in the figure below</p>\n</div>\n</div>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/792ec065b903458b91ca988c98812d96x1280x1995.JPEG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/b1553398af2e42e1a7e03d20a0ab473e.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "ME9359",
      "difficulty": "medium"
    },
    {
      "text": "You notice that a patient is given an inhalational anesthetic through a yellow-colored vaporizer during daycare surgery. Which of the following gases would you expect it to contain?",
      "choices": [
        {
          "id": 1,
          "text": "Sevoflurane"
        },
        {
          "id": 2,
          "text": "Halothane"
        },
        {
          "id": 3,
          "text": "Isoflurane"
        },
        {
          "id": 4,
          "text": "Desflurane"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Sevoflurane</strong> is the&nbsp;inhaled anesthetic, delivered through a <span><strong>yellow</strong></span>-<strong>colored</strong>&nbsp;vaporizer.</p>\n<p><strong>Sevoflurane</strong>&nbsp;is a<strong>&nbsp;fluorinated volatile anesthetic&nbsp;</strong>and is an<strong>&nbsp;ideal induction agent</strong>. Its&nbsp;<strong>non-pungency</strong>&nbsp;and&nbsp;<strong>rapid onset</strong>&nbsp;make it an excellent choice for<strong> smooth</strong> and<strong> rapid inhalation inductions</strong> in pediatric and adult patients.</p>\n<p>Sevoflurane is the&nbsp;<strong>inhalational anesthetic</strong>&nbsp;of choice for <strong>daycare surgery</strong>. The low blood-gas partition coefficient (0.69), blood&ndash;brain coefficient (1.7), and minimal airway irritation of sevoflurane promote&nbsp;<strong>rapid induction</strong>&nbsp;and&nbsp;<strong>rapid recovery.</strong></p><hr><h3>Related Pearl: Color coding of Vaporisers</h3><table>\n<tbody>\n<tr>\n<td><strong>Volatile Agent&nbsp;</strong></td>\n<td><strong>Color</strong></td>\n</tr>\n<tr>\n<td>Halothane</td>\n<td>Red</td>\n</tr>\n<tr>\n<td>Isoflurane</td>\n<td>Purple</td>\n</tr>\n<tr>\n<td>Sevoflurane</td>\n<td>Yellow</td>\n</tr>\n<tr>\n<td>Desflurane</td>\n<td>Blue</td>\n</tr>\n<tr>\n<td>Enflurane</td>\n<td>Orange</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/fdc7f380a095478e876f1db68b009ccfx1280x1644.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Inhalational anaesthetic agents</h3><p>Inhalational agent of choice: </p>\n<table>\n<tbody>\n<tr>\n<td><strong>Indication</strong></td>\n<td><strong>Anesthetic gas</strong></td>\n</tr>\n<tr>\n<td>1. Induction </td>\n<td>Sevoflurane</td>\n</tr>\n<tr>\n<td>2. Daycare surgery</td>\n<td>Sevflurane&gt;Desflurane</td>\n</tr>\n<tr>\n<td>3. Elderly </td>\n<td>Desflurane</td>\n</tr>\n<tr>\n<td>4. Cardiac surgery</td>\n<td>Isoflurane</td>\n</tr>\n<tr>\n<td>5. Renal disease</td>\n<td>Desflurane</td>\n</tr>\n<tr>\n<td>6. Liver disease </td>\n<td>Sevoflurane &gt; Desflurane </td>\n</tr>\n<tr>\n<td>7. Neurosurgery   </td>\n<td>Sevoflurane&gt;Isoflurane</td>\n</tr>\n<tr>\n<td>8. Asthmatics</td>\n<td>Sevoflurane</td>\n</tr>\n<tr>\n<td>9. Obese patients</td>\n<td>Desflurane</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>\n<table>\n<tbody>\n<tr>\n<td><strong>Feature</strong></td>\n<td><strong>Drug</strong></td>\n</tr>\n<tr>\n<td>Most potent      </td>\n<td>Methoxyflurane &gt; Halothane </td>\n</tr>\n<tr>\n<td>Least potent     </td>\n<td>Nitrous oxide &gt; Desflurane </td>\n</tr>\n<tr>\n<td>Most epileptogenic  </td>\n<td>Enflurane</td>\n</tr>\n<tr>\n<td>Most nephrotoxic</td>\n<td>Methoxyflurane </td>\n</tr>\n<tr>\n<td>Most hepatotoxic</td>\n<td>Halothane </td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF8698",
      "difficulty": "medium"
    },
    {
      "text": "A 30-year-old man with a history of chronic rhinosinusitis is referred to the dermatology OPD for abnormal-looking nails as shown in the image. Which of the following is not a feature of this patient’s condition?",
      "choices": [
        {
          "id": 1,
          "text": "Pleural effusion"
        },
        {
          "id": 2,
          "text": "Malignant neoplasms"
        },
        {
          "id": 3,
          "text": "Bronchiectasis"
        },
        {
          "id": 4,
          "text": "Pitting edema"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The condition shown in the above image is <strong><span>yellow</span> nail syndrome</strong>. It is associated with <strong>lymphedema</strong>, which is non-pitting.</p>\n<p>It is a rare disease characterized by the classical triad of:</p>\n<ul>\n<li aria-level=\"1\"><strong><span>Yellow</span> dystrophic nails</strong>, due to thickening of nails</li>\n<li aria-level=\"1\">Primary <strong>lymphedema</strong> (due to underdevelopment of the lymphatic vessels)</li>\n<li aria-level=\"1\"><strong>Pleural effusion</strong></li>\n</ul>\n<p>Other common manifestations include chronic <strong>rhinosinusitis</strong>, chronic <strong>bronchitis</strong>, <strong>bronchiectasis</strong>, increased risk of <strong>malignancy</strong>.</p>\n<p>It is also associated with <strong>D-penicillamine</strong> therapy and <strong>nephrotic</strong> syndrome. Hypothyroidism and AIDS may show yellow nails, but it is unclear whether this is due to yellow nail syndrome or simply due to retarded growth.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/f0b0fbdba6cd40bc8d1ec6a654aad6d1.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MA3350",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following vacutainers is incorrectly matched with their clinical use?",
      "choices": [
        {
          "id": 1,
          "text": "Red vacutainer - Serology tests"
        },
        {
          "id": 2,
          "text": "Purple vacutainer - Routine hematological studies like CBC"
        },
        {
          "id": 3,
          "text": "Blue vacutainer - Coagulation studies"
        },
        {
          "id": 4,
          "text": "Grey vacutainer - HLA typing"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><span><strong>Grey</strong></span> vacutainers are used for the <strong>estimation </strong>of <strong>blood glucose</strong>. It contains&nbsp;<strong>sodium fluoride </strong>which&nbsp;<strong>inhibits glycolysis</strong>. For <strong>HLA typing</strong>&nbsp;and DNA studies,&nbsp;<span><strong>yellow</strong></span> vacutainers&nbsp;containing&nbsp;<strong>acid-citrate dextrose&nbsp;</strong>are used.</p>\n<p>Other options:</p>\n<p>Option A:<strong>&nbsp;<span>Red</span></strong>&nbsp;vacutainers contain <strong>no additives</strong>. They are used for <strong>serum chemistry</strong> tests, <strong>serology&nbsp;tests</strong>, and in blood banks, where serum is required for cross-matching.</p>\n<p>Option B:&nbsp;<span><strong>Purple</strong></span>&nbsp;vacutainers contain<strong>&nbsp;EDTA</strong>.&nbsp;It is used for&nbsp;<strong>routine hematological studies</strong>&nbsp;like <strong>CBC</strong> (Complete blood counts).<br /><br />Option C: <span><strong>Blue</strong></span>&nbsp;vacutainers contain&nbsp;<strong>citrate</strong>. It is used for<strong> coagulation studies</strong>.</p><hr><h3>Related Pearl: Anticoagulants in Vacutainers and their Uses</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/208956b39e504182a7fab1330d186f3cx1280x2189.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF8704",
      "difficulty": "easy"
    },
    {
      "text": "Match the following poisoning with the corresponding color seen during livor mortis.<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td><strong>Poisoning</strong></td>\n<td><strong>Color in Livor Mortis</strong></td>\n</tr>\n<tr>\n<td>1. Hydrocyanic acid</td>\n<td>a. Bluish-green</td>\n</tr>\n<tr>\n<td>2. Phosphorus</td>\n<td>b.&nbsp;Cherry-red</td>\n</tr>\n<tr>\n<td>3. Hydrogen sulfide</td>\n<td>c.&nbsp;Dark-brown</td>\n</tr>\n<tr>\n<td>4.&nbsp;Carbon monoxide</td>\n<td>d. Bright red</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "1-c, 2-a, 3-b, 4-d"
        },
        {
          "id": 2,
          "text": "1-d, 2-c, 3-a, 4-b"
        },
        {
          "id": 3,
          "text": "1-b, 2-d, 3-c, 4-a"
        },
        {
          "id": 4,
          "text": "1-a, 2-b, 3-d, 4-c"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The correct matches are:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Poisoning</strong></td>\n<td><strong>Color in Livor Mortis</strong></td>\n</tr>\n<tr>\n<td>1. Hydrocyanic acid</td>\n<td>d.<span> Bright red</span></td>\n</tr>\n<tr>\n<td>2. Phosphorus</td>\n<td>c.&nbsp;<span>Dark-brown</span></td>\n</tr>\n<tr>\n<td>3. Hydrogen sulfide</td>\n<td>a. <span>Bluish-<span>green</span></span></td>\n</tr>\n<tr>\n<td>4.&nbsp;Carbon monoxide</td>\n<td>b.&nbsp;<span>Cherry-red</span></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Postmortem hypostasis/Postmortem staining/Postmortem lividity/Livor mortis/Suggilation</strong>&nbsp;refers to bluish-purple or reddish-purple discoloration&nbsp;of the superficial layers of the skin due to the collection of blood in toneless capillaries.&nbsp;</p>\n<p>It is an&nbsp;<strong>early</strong>&nbsp;postmortem change that occurs due to<strong>&nbsp;engorged vessels</strong>&nbsp;showing through the skin seen on the&nbsp;<strong>dependent parts</strong>&nbsp;due to the pooling of blood under the effect of gravity.&nbsp;</p>\n<p>This staining starts as<strong>&nbsp;mottled patches</strong><strong>&nbsp;</strong>1-3 hours&nbsp;following death and develops to a&nbsp;<strong>uniform area</strong>&nbsp;of staining in 3-6 hours.&nbsp;Full development and<strong>&nbsp;fixation of hypostasis&nbsp;</strong>occur within&nbsp;<strong>6-12 hours.&nbsp;</strong>This finding<span class=\"s1\">&nbsp;usually develops within 4 hours and&nbsp;<strong>persists until putrefaction.&nbsp;</strong>Fixation of hypostasis&nbsp;occurs&nbsp;<strong>earlier</strong>&nbsp;in&nbsp;<strong>summer.&nbsp;</strong>It&nbsp;is&nbsp;<strong>delayed&nbsp;</strong>in<strong>&nbsp;asphyxial deaths</strong>&nbsp;and in<strong>&nbsp;intracranial lesions</strong>.</span></p><hr><h3>Related Pearl: Color of Postmortem Hypostasis in Various Conditions</h3><table>\n<tbody>\n<tr>\n<td><strong>Poisoning/Condition</strong></td>\n<td><strong>Postmortem staining</strong></td>\n</tr>\n<tr>\n<td>\n<p>Carbon monoxide   </p>\n</td>\n<td>\n<p>Cherry red</p>\n</td>\n</tr>\n<tr>\n<td>Cyanides     </td>\n<td>\n<p>Brick red/dark pink</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Potassium chlorate</p>\n</td>\n<td>Chocolate brown </td>\n</tr>\n<tr>\n<td>Phosphorous </td>\n<td>Dark brown </td>\n</tr>\n<tr>\n<td>Nitrites   </td>\n<td>\n<p>Red-brown</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hydrogen sulphide</p>\n</td>\n<td>\n<p>Bluish-green</p>\n</td>\n</tr>\n<tr>\n<td>Opium </td>\n<td>Greyish/black</td>\n</tr>\n<tr>\n<td>Asphyxia</td>\n<td>Dark purple</td>\n</tr>\n<tr>\n<td>Hypothermia</td>\n<td>Bright pink</td>\n</tr>\n<tr>\n<td>Septic abortion (Cl. Perfringens infection)</td>\n<td>Pale bronze</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1032",
      "difficulty": "easy"
    },
    {
      "text": "Which of the following bio-medical waste materials are disposed off in yellow bags?<div class='question-desc-html'><ol>\n<li>Expired drugs</li>\n<li>Latex gloves</li>\n<li>Placenta</li>\n<li>Blood bag</li>\n<li>Used pacemaker</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1, 3, 4"
        },
        {
          "id": 2,
          "text": "2, 3, 4"
        },
        {
          "id": 3,
          "text": "3, 4, 5"
        },
        {
          "id": 4,
          "text": "1, 3, 5"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Expired <strong>drugs</strong>, <strong>placenta</strong>, and <strong>blood bags</strong> are disposed of in <span><strong>yellow</strong></span>-colored&nbsp;containers or non-chlorinated plastic bags.</p>\n<p><strong>Latex gloves</strong> are disposed of in <strong>red</strong>-colored containers.</p>\n<p><strong>Used pacemakers</strong> are discarded in <strong>blue</strong>-colored containers.</p><hr><h3>Related Pearl: Biomedical waste disposal</h3><p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"2\">\n<p><span><strong>&nbsp;<span> Yellow bag </span></strong><strong><span>(non-chlorinated)</span></strong><strong><span>&nbsp;</span>&nbsp;</strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Type of Waste</p>\n</td>\n<td>&nbsp;Treatment and Disposal Options</td>\n</tr>\n<tr>\n<td>\n<p><strong>Human anatomical waste</strong></p>\n<p><strong>Animal anatomical waste</strong></p>\n</td>\n<td>\n<p><strong>Incineration</strong>/Plasma pyrolysis/Deep Burial</p>\n</td>\n</tr>\n<tr>\n<td><strong>Soiled Waste: </strong>Items like dressings, cotton swabs, and plaster casts contaminated with blood and body fluids and bags containing residual discarded blood.</td>\n<td>\n<p><strong>Incineration</strong>/Plasma pyrolysis/Deep Burial</p>\n<p>or</p>\n<p>Autoclaving/Microwaving/ Hydroclaving</p>\n<p>Later - Shredding/mutilation</p>\n</td>\n</tr>\n<tr>\n<td>Discarded linen, mattresses, beddings contaminated with blood or body fluid,<strong> routine masks, and gowns</strong></td>\n<td>\n<p>Non- chlorinated chemical disinfection<br />followed by incineration or Plazma<br />Pyrolysis or for energy recovery.<br />In absence of the above facilities, shredding,&nbsp;mutilation, or a combination of&nbsp;sterilization and shredding is used.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Microbiology, biotechnology, clinical laboratory waste</strong></p>\n<p>(Autoclave safe plastic bags used)</p>\n<p><strong>Blood bags</strong>, laboratory<br />cultures, stocks or&nbsp;specimens of microorganisms,<br />live or&nbsp;attenuated vaccines,&nbsp;human and animal cell&nbsp;cultures used in&nbsp;research, industrial&nbsp;laboratories, production&nbsp;of biological, residual&nbsp;toxins, dishes, and&nbsp;devices used for&nbsp;cultures.</p>\n</td>\n<td>\n<p>Pre-treatment with nonchlorinated chemicals</p>\n<p>Later - Incineration</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Expired/discarded medicine, cytotoxic drugs</p>\n</td>\n<td>Incineration/plasma pyrolysis/ disposal in a secured landfill</td>\n</tr>\n<tr>\n<td>&nbsp;\n<p><strong>Chemical waste</strong></p>\n<p>Chemicals used in biological production&nbsp;and used or discarded<br />disinfectants.</p>\n</td>\n<td>\n<p>Disposal- incineration/plasma<br />pyrolysis</p>\n<p>Encapsulation-&nbsp;hazardous waste treatment, storage, and&nbsp;disposal facility.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Chemical liquid</strong>&nbsp;<strong>waste</strong> :<br />Liquid waste generated&nbsp;due to the use of chemicals&nbsp;in the production of<br />biological and used or&nbsp;<strong>discarded disinfectants,</strong>&nbsp;silver X-ray film<br />developing liquid,<br />discarded formalin,<br />infected <strong>secretions,</strong><br /><strong>aspirated body&nbsp;fluids</strong>,&nbsp;liquid from&nbsp;laboratories and floor&nbsp;washings, cleaning,&nbsp;house-keeping and<br />disinfecting activities&nbsp;etc.</p>\n<p>&nbsp;</p>\n</td>\n<td>After resource recovery, the chemical<br />liquid waste shall be pre-treated before&nbsp;mixing with other wastewater.&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"2\">\n<p><span><strong>&nbsp; Red&nbsp;bag (non-chlorinated)&nbsp;&nbsp;</strong></span></p>\n</td>\n</tr>\n<tr>\n<td><strong>&nbsp;Type of Waste</strong></td>\n<td>\n<p><strong>&nbsp;<span>Treatment and Disposal Options</span></strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Recyclable contaminated</strong> waste</p>\n<p>Contaminated waste tubing, bottles, intravenous tubes and sets, <strong>catheters,</strong> <strong>urine bags</strong>, syringes (without needles and fixed needle syringes with their needles cut), <strong>vacutainers with</strong> <strong>needles cut,</strong> and gloves.</p>\n</td>\n<td>\n<p><strong>Autoclaving/Microwaving/<br />Hydroclaving</strong></p>\n<p>Followed by Shredding/mutilation</p>\n<p>And later, Energy recovery/Plastics to diesel or fuel oil/road-making</p>\n<p>Not to be sent to landfill</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"2\">\n<p><strong>&nbsp; White (translucent)&nbsp;&nbsp;<br />(puncture-proof, leak-proof containers)</strong></p>\n</td>\n</tr>\n<tr>\n<td><strong>Type of Waste</strong></td>\n<td>\n<p><strong>Treatment and Disposal Options</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Waste Sharps including metals.</strong></p>\n<p>Needles, syringes with fixed needles, needles from needle tip cutter or burner, scalpels, blades, or any other <strong>contaminated sharp</strong> object that may cause puncture and cuts. This includes both used, discarded, and contaminated metal sharps</p>\n</td>\n<td>\n<p>Autoclaving/ Dry heat sterilization</p>\n<p>Followed by - <strong>Shredding/mutilation</strong>/<br />encapsulation</p>\n<p>Later by - Iron foundries/sanitary landfill/waste sharps</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"2\">\n<p>&nbsp;<span><strong><span>&nbsp; Blue&nbsp;&nbsp;</span><br /></strong></span><span><strong><span>(Puncture proof and leak proof containers with blue colored marking)</span></strong></span></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Type of Waste&nbsp;</strong></p>\n</td>\n<td>\n<p><strong>&nbsp;Treatment and Disposal Options</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Glassware</strong></p>\n<p>Broken or discarded and contaminated glass including medicine <strong>vials</strong> and <strong>ampules except</strong> those containing <strong>cytotoxic</strong> waste.</p>\n<p><strong>Metallic body implants</strong></p>\n</td>\n<td>\n<p>Sodium hypochlorite/Autoclaving/<br />Microwaving/Hydroclaving</p>\n<p>Later - Recycling</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>&nbsp;Note: <strong>Ash</strong> from the <strong>incineration</strong> of biomedical waste shall be disposed of at a <strong>common hazardous waste treatment and disposal facility</strong>. However, it may also be disposed of in a <strong>municipal landfill</strong>, <strong>if</strong> the toxic metals in incineration ash are <strong>within</strong> the <strong>regulatory quantities</strong> as defined under the Hazardous Waste (Management and Handling and Transboundary Movement) Rules, 2008 as amended from time to time.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1650",
      "difficulty": "medium"
    },
    {
      "text": "An 8-year-old boy presenting with photophobia, sweating,  joint pains, and puffy, painful, pinkish hands and feet, is suspected to have pink disease caused due to a chronic metal poisoning. Which of the following is not associated with the poisoning by this metal?",
      "choices": [
        {
          "id": 1,
          "text": "Danbury tremors"
        },
        {
          "id": 2,
          "text": "Erethism"
        },
        {
          "id": 3,
          "text": "Minamata disease"
        },
        {
          "id": 4,
          "text": "Aldrich mees lines"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Pink<span> </span>disease</strong> is seen in chronic <strong>mercury </strong>poisoning. <strong>Aldrich mees lines</strong> are characteristic of chronic <strong>arsenic</strong> poisoning, not mercury.</p>\n<p><strong>Pink disease</strong> or <strong>acrodynia</strong> occurs due to an <strong>idiosyncratic hypersensitivity reaction</strong> resulting from chronic exposure to <strong>mercury </strong>and is seen particularly in <strong>children</strong>. The onset is insidious with anorexia, <strong>sweating,</strong> <strong>skin rash</strong>, insomnia, and <strong>photophobia</strong>. Hands and feet become <strong>puffy, pinkish</strong>, and<strong> painful</strong>. Associated <strong>joint pain</strong>, paresthesia, shedding of teeth, and skin <span>peeling</span> are also seen.</p>\n<p>Other eponymous features associated with <strong>mercury poisoning</strong>:</p>\n<ul>\n<li><span data-preserver-spaces=\"true\"><strong>Danbury tremors</strong> are coarse, intentional tremors. The advanced condition is called <strong>Hatter's shakes</strong>/<strong>Glass blower's</strong> <strong>shakes</strong>.</span></li>\n<li><span data-preserver-spaces=\"true\"><span data-preserver-spaces=\"true\"><strong>Minamata disease</strong>: This is caused by the <strong>eating</strong> of<strong> fish poisoned</strong> by <strong>mercury</strong>. The i</span></span>ndustrial discharges of mercury into <strong>Minamata Bay</strong> in Japan became biomethylated to form <strong>methyl mercury</strong>, which then accumulated in fish. On consumption of these fishes, people developed <strong>visual deficits</strong> and several neurological manifestations such as <strong>loss of sensation</strong>, <strong>gait</strong>, <strong>memory</strong>, cognition, etc.</li>\n<li><span data-preserver-spaces=\"true\"><strong>Erethism</strong>: These are psychological symptoms due to mercury toxicity, which is seen among persons working in mirror manufacturing firms. It is characterized by <strong>shyness</strong>, <strong>timidity</strong>, irritability, loss of confidence, <strong>mental depression</strong>, loss of memory, and insomnia.</span></li>\n<li><span data-preserver-spaces=\"true\"><strong>Mercuria lentis</strong>: This term refers to the peculiar eye change seen due to exposure to mercury vapor. It appears as<strong> brownish deposits</strong> of mercury on the <strong>anterior lens capsule</strong>.</span></li>\n</ul>\n<p>The image below shows <strong><span>transverse white</span> lines </strong>(Leukonychia striata) called <strong>Aldrich Mees Lines </strong>typically seen in <strong>arsenic poisoning</strong>.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/fd851163402d4a708b7c0825c078c93ex720x616.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Mercury Poisoning</h3><table>\n<tbody>\n<tr>\n<td>Features</td>\n<td>\n<p>Mercury</p>\n</td>\n</tr>\n<tr>\n<td>Source of exposure</td>\n<td>\n<p>Thermometers (elemental mercury)</p>\n<p>Industries (inorganic mercury)</p>\n<p>Fish (organic mercury) </p>\n</td>\n</tr>\n<tr>\n<td>Route of absorption</td>\n<td>\n<p>Elemental - Respiratory tract (negligible through GI unless the mucosa is damaged) </p>\n<p>Inorganic - GI tract</p>\n<p>Organic - GI tract</p>\n</td>\n</tr>\n<tr>\n<td>Mechanism of action</td>\n<td>\n<p>binds to sulhydryl groups of enzymes and affects</p>\n<ul>\n<li>glutathione metabolism</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Organs affected (acute toxicity)</td>\n<td>\n<p>Respiratory tract (elemental mercury)</p>\n<p>GI tract (inorganic mercury)</p>\n<p>Respiratory + GI tract (organic mercury)</p>\n</td>\n</tr>\n<tr>\n<td>Organs affected (chronic toxicity)</td>\n<td>\n<p>CNS, Renal (elemental mercury)</p>\n<p>Renal (inorganic mercury)</p>\n<p>CNS (organic mercury)</p>\n</td>\n</tr>\n<tr>\n<td>Characteristic clinical findings</td>\n<td>\n<p> </p>\n<p><strong>Mnemonic: MEATS</strong></p>\n<p><strong>M</strong> -</p>\n<ul>\n<li>Mercuria lentis</li>\n<li>Membranous colitis </li>\n<li>Minimata disease</li>\n<li>Membranous glomerulopathy</li>\n</ul>\n<p><strong>E-</strong>Erethism (personality disturbance, insomnia, and loss of memory)</p>\n<p><strong>A</strong>-Acrodynia (Pink disease)</p>\n<p><strong>T-</strong>Tremors (Coarse tremors) - Include Danbury tremors, hatter’s or Glass blower’s shakes</p>\n<p><strong>S-</strong>Salivation (excessive salivation)</p>\n</td>\n</tr>\n<tr>\n<td>Diagnosis</td>\n<td>Blood and/or 24 hour urine mercury level</td>\n</tr>\n<tr>\n<td>Treatment</td>\n<td>BAL; succimer(DMSA)</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Arsenic poisoning</h3><p>Summary of Arsenic poisoning</p>\n<p><strong>Source of exposure</strong>:&nbsp;Arsenic-containing pesticides, natural sources - drinking water and soil</p>\n<p><strong>Route of absorption</strong>:&nbsp;GI tract</p>\n<p><strong>Mechanism of action</strong>:&nbsp;binds to sulfhydryl groups and inhibits pyruvate dehydrogenase, gluconeogenesis, glutathione metabolism</p>\n<p>Characteristic clinical findings are as follows: Mnemonic-ARSENIC</p>\n<p><strong>A-&nbsp;</strong>Aldrich mees lines</p>\n<p><strong>R-&nbsp;</strong>raindrop pigmentation, rash,&nbsp;red velvety mucosa</p>\n<p><strong>S-&nbsp;</strong>subendocardial haemorrhage</p>\n<p><strong>E-&nbsp;</strong>Excessive pigmentation- Blackfoot&nbsp;disease</p>\n<p><strong>N-&nbsp;</strong>Neuritis</p>\n<p><strong>I-&nbsp;</strong>Iron oxide + BAL &ndash;treatment</p>\n<p><strong>C-&nbsp;</strong>Cholera like illness</p>\n<p><strong>Diagnosis</strong>:&nbsp;24-hour urine arsenic</p>\n<p><strong>Treatment</strong>:&nbsp;BAL; succimer(DMSA)</p>\n<p>Clinicopathological findings in acute and chronic arsenic poisoning:</p>\n<table>\n<tbody>\n<tr>\n<td>\n<p><strong>System</strong></p>\n</td>\n<td>\n<p><strong>Acute</strong></p>\n</td>\n<td>\n<p><strong>Chronic</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Skin</p>\n</td>\n<td>\n<p>Delayed hair loss (alopecia)</p>\n</td>\n<td>\n<p>Melanosis, Bowen&rsquo;s disease facial edema, hyperkeratosis, cutaneous cancer, hyperpigmentation.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Nails</p>\n</td>\n<td>\n<p>Mees&rsquo;s lines in 2-3 weeks post ingestion.</p>\n</td>\n<td>\n<p><strong>Mees' lines</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Neurologic</p>\n</td>\n<td>\n<p>Hyperpyrexia, convulsions, tremors, coma</p>\n</td>\n<td>\n<p>Encephalopathy, polyneuropathy, tremors, axonal degeneration</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>GI tract</p>\n</td>\n<td>\n<p>Abdominal pain, dysphagia, vomiting, bloody or rice water diarrhea, mucosal erosions.</p>\n</td>\n<td>\n<p>Nausea, vomiting, diarrhea, anorexia, weight loss</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Liver</p>\n</td>\n<td>\n<p>Fatty infiltration</p>\n</td>\n<td>\n<p>Hepatomegaly, jaundice, cirrhosis</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Kidney</p>\n</td>\n<td>\n<p>Tubular and glomerular changes &ndash; oliguria and uremia</p>\n</td>\n<td>\n<p>Nephritic finding</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Haemetologic</p>\n</td>\n<td>\n<p>thrombocytopenia, impaired folate metabolism</p>\n</td>\n<td>\n<p>Bone marrow hypoplasia, anemia, leukopenia, basophilic stippling, and karyorrhexis.</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cardiovascular</p>\n</td>\n<td>\n<ul>\n<li>S-T wave abnormalities,</li>\n<li>prolonged QT interval</li>\n<li>ventricular fibrillation</li>\n<li>atypical ventricular tachycardia&nbsp;</li>\n</ul>\n</td>\n<td>\n<p>There is platelet activation and hypercoagulability of blood in peripheral arteries leading to blackfoot disease</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Reproductive system</p>\n</td>\n<td>\n<p>Maternal ingestion of inorganic</p>\n<p>Arsenic crosses the placental barrier and infant death shortly after birth.</p>\n</td>\n<td>\n<p>-Nil-</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF8722",
      "difficulty": "medium"
    },
    {
      "text": "A 25-year-old patient came to the Suraksha clinic with the following presentation in the right inguinal region.  Which of the following kits should be given to treat this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Grey kit"
        },
        {
          "id": 2,
          "text": "Blue kit"
        },
        {
          "id": 3,
          "text": "Red kit"
        },
        {
          "id": 4,
          "text": "Black kit"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The<strong> <span>black kit</span></strong> should be used for the treatment of this patient. In the image shown above, the <strong>groove sign</strong> is seen in the<strong> inguinal region</strong>. It is the characteristic feature of <strong>lymphogranuloma venereum </strong>caused by <em>Chlamydia trachomatis</em>.</p>\n<p>The<strong> <span>black kit</span></strong> comprises of tablet <strong>azithromycin 1 gm</strong> single dose + <strong>tablet doxycycline 100 mg</strong> twice daily for 21 days.</p>\n<p>It is used in the <strong>following presentation</strong>:</p>\n<ul>\n<li>Swelling in the inguinal region may be painful</li>\n<li>The preceding history of genital ulcer or discharge</li>\n<li>Systemic symptoms like malaise, fever, etc.</li>\n</ul>\n<p>All&nbsp;<strong>partners </strong>in the last<strong> 3 weeks</strong> should be<strong>&nbsp;treated</strong>.</p>\n<p>Other options:</p>\n<p>Option A - The <span><strong>grey kit</strong></span> is used in men for <strong>urethral discharge</strong> and <strong>scrotal swelling</strong>. All <strong>recent partners</strong>&nbsp;should be <strong>treated</strong>. However, when used for cervical discharge in women, only symptomatic male partners need to be treated.</p>\n<p>Option B - The <span><strong>blue kit</strong></span> is used in <strong>non-herpetic genital ulcer disease</strong> when the patient is <strong>allergic</strong> to <strong>penicillin</strong>. All <strong>partners</strong> in the last <strong>3 months</strong> should be treated.</p>\n<p>Option C - The <span><strong>red kit</strong></span> is used in<strong> herpetic genital ulcer disease,</strong> in which the <strong>treatment</strong> of <strong>asymptomatic</strong> partners is <strong>not</strong> <strong>required</strong>.</p><hr><h3>Related Pearl: Syndromic Management of Sexually Transmitted Infections</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1167210a9cd6434a905a98bc64668d41x1280x2612.PNG\" alt=\"Pearl Image\"><p>Partner Management when <strong>asymptomatic</strong> is not required for <strong>Gardenella vaginalis, Candida and Herpes infections</strong>.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/60da7b1257d04ca5938ef3340533e6b9x1280x2974.JPEG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/b04f1866ba754fe68e93d9eed60b3bdc.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF1512",
      "difficulty": "medium"
    },
    {
      "text": "During an ophthalmoscopic examination of a patient in bright light, you notice that the fundus has a golden yellow color in the light-adapted state. The same patient is made to sit in a dark room and a subsequent examination reveals a normal fundus after prolonged dark adaptation. What is the possible diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Oguchis disease"
        },
        {
          "id": 2,
          "text": "Retinitis pigmentosa"
        },
        {
          "id": 3,
          "text": "Fundus albipunctatus"
        },
        {
          "id": 4,
          "text": "Fundus flavimaculatus"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>This unusual presentation of the fundus showing a <span>golden yellow</span> color in light and a normal color in dark adaptation is known as<strong> Mizuo or Mizuo–Nakamura phenomenon</strong> and is seen in <strong>Oguchi's disease.</strong></p>\n<p>It is a type of<strong> congenital stationary night blindness</strong> with<strong> abnormal fundus. </strong>The following image shows a comparison in the fundus appearances (\"A\" shows the <span>golden yellow</span> color of the fundus in a light-adapted state; \"B\" shows normal-appearing funds after prolonged dark adaptation of 3 to 4 hours).</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/bba1501381694da898eef3180601b8d6x512x219.JPEG\" alt=\"Explanation Image\"><p><strong>Rod</strong> <strong>function</strong> is <strong>absent</strong> even after <strong>30 minutes</strong> of <strong>dark adaptation </strong>(normal dark adaptation time is 20–30 mins) but recovers to a near-normal level after a long period of dark adaptation (4 hours).</p>\n<p><strong>Congenital stationary night blindness</strong> refers to a group of disorders characterised by<strong> infantile-onset nyctalopia</strong> but <strong>non-progressive retinal dysfunction.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD3739",
      "difficulty": "medium"
    },
    {
      "text": "A pathologist is examining a specimen from a patient with amyloidosis. When amyloid is stained with Congo red and visualized under ordinary light, which color does it acquire?",
      "choices": [
        {
          "id": 1,
          "text": "White"
        },
        {
          "id": 2,
          "text": "Apple-green birefringence"
        },
        {
          "id": 3,
          "text": "Red"
        },
        {
          "id": 4,
          "text": "Dark brown"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>When amyloid is stained with <strong>Congo <span>red</span></strong> and is visualized under ordinary light, it shows&nbsp;<strong>red colour.</strong></p>\n<p><strong>Amyloidosis</strong> results from the&nbsp;<strong>abnormal folding of proteins</strong>, which become insoluble, get aggregated, and are deposited as <strong>fibrils</strong> in <strong>extracellular</strong> tissues. Normally, misfolded proteins are degraded. Amyloid may be <strong>systemic</strong> (generalized), involving several organ systems, or it may be <strong>localized</strong>&nbsp;to a single organ.</p>\n<div class=\"page\" title=\"Page 268\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>The histologic diagnosis of amyloid is based almost entirely on its staining characteristics:</p>\n<p>1. Light microscopy&nbsp;with <strong>hematoxylin </strong>and <strong>eosin</strong> stain:<strong>&nbsp;</strong>Amyloid appears as an <strong>amorphous, eosinophilic, hyaline</strong>&nbsp;substance in extracellular space.</p>\n<p>2. <strong>Congo red stain</strong>:&nbsp;</p>\n</div>\n</div>\n</div>\n</div>\n<ul>\n<li><strong>Under ordinary light</strong>, it imparts a <strong>pink</strong> or <strong><span>red</span> color</strong> to tissue deposits.</li>\n<li><strong>Under the polarizing microscope</strong>,&nbsp;it imparts <strong><span>apple-green</span> birefringence</strong>&nbsp;to amyloid deposits.</li>\n</ul>\n<p>Images below show amyloid stained with congo red stain, under ordinary light, and under polarised light respectively</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/d059b4d8f34c4f00899519648f228d58x640x480.JPEG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/08c75b99c8fd40ce822121f787ae58f8x720x540.JPEG\" alt=\"Explanation Image\"><p>3.&nbsp;<strong>Electron microscopy:&nbsp;</strong>All types of amyloid are seen as continuous, nonbranching, nonoriented, thin fibrils</p>\n<p>4.&nbsp;<strong>X-ray crystallography and infrared spectroscopy: </strong>Characteristic cross-&beta;-pleated sheet conformation of amyloid is seen. This conformation is actually responsible for the Congo red staining and birefringence of amyloid.</p><hr><h3>Related Pearl: Appearance of Amyloid</h3><table>\n<tbody>\n<tr>\n<td><strong>Methods</strong></td>\n<td><strong>Appearance</strong></td>\n</tr>\n<tr>\n<td>On light microscopy and standard tissue stains&nbsp;(H&amp;E)&nbsp;</td>\n<td>Amorphous eosinophilic extracellular substance&nbsp;</td>\n</tr>\n<tr>\n<td>Congo red stain on ordinary light&nbsp;&nbsp;&nbsp;</td>\n<td>Pink or red&nbsp;colour&nbsp;to tissue deposits&nbsp;</td>\n</tr>\n<tr>\n<td>Congo red stain on polarizing microscopy&nbsp;&nbsp;</td>\n<td>Apple-green birefringence&nbsp;</td>\n</tr>\n<tr>\n<td>Fluorescent stains (thioflavin T and S)&nbsp;&nbsp;&nbsp;</td>\n<td>Yellow&nbsp;colour&nbsp;under UV light&nbsp;</td>\n</tr>\n<tr>\n<td>Electron microscopy&nbsp;</td>\n<td>Nonbranching fibrils of indefinite length and a&nbsp;diameter of approximately 7.5 to 10 nm.&nbsp;</td>\n</tr>\n<tr>\n<td>X-ray crystallography and infrared spectroscopy&nbsp;</td>\n<td>Characteristic cross &beta; pleated sheet conformation&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>H&amp;E: Hematoxylin and eosin &nbsp;</p><hr><h3>Related Pearl: Classification of Amyloidosis</h3><div class=\"page\" title=\"Page 270\">\n<table><colgroup><col /><col /><col /><col /> </colgroup>\n<tbody>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Clinicopathologic Category</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Major Fibril Protein</strong></p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Chemically Related Precursor Protein</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\"3\" rowspan=\"1\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Systemic (Generalized) Amyloidosis:</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Immunoglobulin light chain amyloidosis (<strong>primary amyloidosis</strong>)</p>\n<p>Seen in Multiple myeloma and other monoclonal plasma cell proliferation</p>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>AL</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Immunoglobulin light chains, chiefly &lambda; type</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Reactive systemic amyloidosis (<strong>secondary amyloidosis</strong>)</p>\n<p>Seen in chronic inflammatory conditions</p>\n</div>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>AA</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>SAA</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Hemodialysis-associated amyloidosis</p>\n<p>Seen in chronic renal failure</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>A&beta;2m</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>&beta;2-microglobulin</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\"3\" rowspan=\"1\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Hereditary Amyloidosis:</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Familial Mediterranean fever</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>AA</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>SAA</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Familial amyloidotic neuropathies</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>ATTR</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Mutated transthyretin</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Systemic senile amyloidosis</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>ATTR</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Normal transthyretin</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td colspan=\"3\" rowspan=\"1\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><strong>Localized Amyloidosis:</strong></p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Senile cerebral amyloidosis</p>\n<p>Seen in Alzheimer's disease</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>A&beta;</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>APP</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Endocrine disorders like Type 2 diabetes</p>\n</div>\n</div>\n</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Medullary carcinoma thyroid</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>A Cal</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Calcitonin</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Islets of Langerhans</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>AIAPP</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Islet amyloid peptide</p>\n</div>\n</div>\n</td>\n</tr>\n<tr>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Isolated atrial amyloidosis</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>AANF</p>\n</div>\n</div>\n</td>\n<td>\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Atrial natriuretic factor</p>\n</div>\n</div>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD2580",
      "difficulty": "medium"
    }
  ]
}